Remove Patient-Centered Remove Presentation Remove Provider Remove Specialization
article thumbnail

Deprescribing Super Special Part II: Podcast with Elizabeth Bayliss, Ariel Green, and Kevin McConeghy

GeriPal

A year ago we did our first “Deprescribing Super Special”. Alex: And we have Kevin McConeghy, who is a clinical pharmacy specialist at the VA Medical Center in Providence, and a PhD candidate at the Brown School of Public Health. Eric: So we’re calling this a deprescribing super special. Summary Transcript Summary.

article thumbnail

Episode 354: Antiracism in Medicine – Episode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meeting

The Clinical Problem Solvers

Cooper September 19, 2024 Summary : This episode highlights a selection of antiracism research presentations at a live recording of the podcast at the 2024 SGIM Annual Meeting. She has advanced training in Quality Improvement and Patient Safety Science. During this episode, we hear from Dr. S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Younger Adults Shouldn’t Skip Cholesterol Screenings

Imperial Center Family Medicine

Know Your Baseline Your first cholesterol screening in your 20s or 30s provides a baseline for future test results. Accommodate Special Considerations Certain groups are particularly at risk for early heart disease tied to high cholesterol. Statins may plausibly provide greater preventive impact the earlier they are started.

article thumbnail

Episode 181: Antiracism in Medicine Series – Episode 9 – Moving Towards Antiracism in Medical Education

The Clinical Problem Solvers

[link] Summary In this special episode of the Antiracism in Medicine Series, originally recorded for the 2021 Society of General Internal Medicine Annual Meeting, the CPSolvers Antiracism team discusses what must be done to make medical education more antiracist. board examinations and mandated competencies).

article thumbnail

While the Orphan Battles Wages, Jazz Takes a Loss

FDA Law Blog

As the Court explains, an orphan drug may not be the “same drug” as the same active moiety under the Orphan Drug Act and FDA’s longstanding implementing regulations if one is “clinically superior” than the other by way of greater efficacy, greater safety, or major contribution to patient care (“MC-to-PC”).

Clinic 111
article thumbnail

Screening for Dementia: A Podcast with Anna Chodos, Joseph Gaugler and Soo Borson

GeriPal

Joseph Gaugler is the Director of the Center for Healthy Aging and Innovation at the University of Minnesota, director of the BOLD Public Health Center of Excellence on Dementia Caregiving, and Editor-in-Chief of the Gerontologist. Who should get it if anyone? What should we use to screen individuals? Is that right, Soo? Joe 01:15 Yes.

Screening 119
article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

19:05 Clarifying the “ethics vs science” argument and critiquing research techniques 22:00 Resurgence of race-based speculation in COVID-19-related research 25:57 Implantation of ideas about innate racial inferiority within medicine 28:32 Will removal of race from algorithms potentially harm our patients?

Clinic 52